Clinical Trial Update: MGTA-145 + Plerixafor in the Mobilization of HSCs for Allogeneic Transplant in Hematologic Malignancies [Phase 2]

View source ↗

Summary

Phase 2 study evaluating MGTA-145 in combination with Plerixafor for mobilizing hematopoietic stem cells for allogeneic transplantation in hematologic malignanc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• MGTA-145
• Plerixafor (Plerixafor)

Snippet

Sponsor: Ensoma | Conditions: Related Donors Donating PBSC to a Family Member, Healthy Donors | Phase 2 | Status: TERMINATED | Results posted: 2024-08-29